Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.61
Delayed Data
As of Apr 25
 +0.04 / +0.88%
Today’s Change
3.92
Today|||52-Week Range
8.38
-0.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-23.0M-86.5M-23.5M-30.4M
 
 
 
 
 
Depreciation229.0K230.0K230.0K248.0K
 
 
 
 
 
Total Other Cash Flow3.8M66.5M4.6M9.3M
 
 
 
 
 
Funds From Operations-18.9M-19.8M-18.6M-21.2M
 
 
 
 
 
Funds From/For Other Operating Expenses7.0M-1.6M10.6M-989.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-26.0M-18.2M-29.2M-20.2M
 
 
 
 
 
 
InvestingCapital Expenditures0.00-420.0K-756.0K-81.0K
 
 
 
 
Net Cash Flow Investing0.00-420.0K-756.0K-81.0K
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.00--------
Long Term Debt Reduction0.00--------
Net Proceeds Stock Sale5.1M68.2M3.4M86.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00302.0K
 
 
Net Cash Flow - Financing5.1M68.2M3.4M-216.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-20.9M49.6M-26.5M-20.5M